• Home
• Contact Us
• English | Français

• Corporate
  • Corporate Profile
  • Management Team
  • Board of Directors
  • Charter
  • Mandate of the Audit Committee
  • Code of Ethics
  • Contact Us
• Technology
  • Technology platforms
  • About DAC™
  • About PC-DAC™
  • DAC™ Animation
• Products
  • PC-DAC™:Exendin-4
  • PC-DAC™:Insulin
  • DAC™:HIV
• Partnering
• Investors
  • Company Overview
  • Challenges
  • Business of ConjuChem
  • Benefits of Technology
  • Shareholder Value
  • Financial Information
  • Press Releases
• Glossary

Products

• Product Pipeline
• PC-DAC™:Exendin-4 (CJC-1134-PC)
• PC-DAC™:Insulin
• DAC™:HIV

ConjuChem Pipeline

The following drugs are currently in compounds in research and development:

• PC-DAC™:Exendin-4 (CJC-1134-PC)
• PC-DAC™:Insulin
• DAC™:HIV

They are based on the Drug Affinity Complex (DAC™) and Preformed Conjugate-Drug Affinity Complex (PC-DAC™).

© 1999-2007, ConjuChem, Inc. All rights reserved.